Company news
Immunic, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Immunic AG Awarded Research Grant by German Federal Ministry of Education and Research in Support of the InnoMuNiCH Project
July 31, 2019
Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer
July 15, 2019
Immunic, Inc. Files Financial Statements and Pro Forma Financial Information in Accordance with Previously Completed Stock-for-Stock Exchange Transaction and Provides Corporate Update
June 20, 2019
Immunic, Inc. to Participate in Investor and Scientific Conferences in June
May 29, 2019
Immunic Therapeutics and Vital Therapies Complete Transaction Creating Nasdaq-Listed Company Targeting Chronic Inflammatory and Autoimmune Diseases
April 11, 2019
Calls
The 5 newest of 13 calls. Every call is listed under its year.
- Immunic (NASDAQ:IMUX) Q3 2024 Earnings Call
Nov 7, 2024
Transcript - Immunic (NASDAQ:IMUX) Q2 2024 Earnings Call
Aug 8, 2024
Transcript - Immunic (NASDAQ:IMUX) Q1 2024 Earnings Call
May 8, 2024
Transcript - Immunic (NASDAQ:IMUX) Q4 2023 Earnings Call
Feb 22, 2024
Transcript - Immunic (NASDAQ:IMUX) Q3 2023 Earnings Call
Nov 14, 2023
Transcript
Decks
The 5 newest of 68 decks. Every deck is listed under its year.
- Investor Presentation (October 2026)
Investor deck · 40 slides · October 2026
- Investor Day (September 2026)
Investor day · 58 slides · Sep 9, 2026
- Investor Presentation (September 2026)
Investor deck · 35 slides · September 2026
- Investor Presentation (July 2026)
Investor deck · 35 slides · Jul 14, 2026
- EFMC-ACSMEDI MedChem Frontiers 2026
Conference · 18 slides · Jun 25, 2026